Enhanced Recovery Pathway Helpful in Gyn-Onc Surgery

Share this content:
Enhanced Recovery Pathway Helpful in Gyn-Onc Surgery
Enhanced Recovery Pathway Helpful in Gyn-Onc Surgery

FRIDAY, June 17, 2016 (HealthDay News) -- An enhanced recovery pathway is beneficial for gynecologic oncology patients undergoing minimally invasive surgery, according to a study published in the July issue of Obstetrics & Gynecology.

Jocelyn S. Chapman, M.D., from the University of California, San Francisco, and colleagues conducted a retrospective study involving gynecologic oncology patients who underwent laparoscopic or robotic surgery on an enhanced recovery pathway and were matched with historical controls. The pathway included patient education; multimodal analgesia; opioid minimization; nausea prophylaxis; and early catheter removal, ambulation, and feeding.

The final cohort included 165 patients, of whom 55 were enhanced recovery pathway patients. The researchers found that, compared with patients in the control group, enhanced recovery patients were more likely to be discharged on postoperative day one (60 versus 91 percent; odds ratio, 6.7). Fifteen and 4 percent of enhanced recovery patients and historical controls, respectively, achieved discharge by noon. Despite a 30 percent reduction in opioid use, postoperative pain scores decreased (2.6 versus 3.12). The enhanced recovery group had a 12 percent decrease in average total hospital costs ($13,771 versus $15,649). No between-group differences were seen in readmission rates, mortality, or reoperation rates.

"An enhanced recovery pathway in patients undergoing gynecologic oncology minimally invasive surgery is associated with significant improvements in recovery time, decreased pain despite reduced opioid use, and lower overall hospital costs," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Keytruda for All Cancers With Genetic Biomarker

FDA Approves Keytruda for All Cancers With Genetic ...

First medication sanctioned for any cancer, regardless of origin

Regular Chocolate Consumption May Lower Risk of A-Fib

Regular Chocolate Consumption May Lower Risk of A-Fib

13-year study finds lower odds for atrial fibrillation in people eating moderate amounts

Doctors Urged to Check Patient Drug History Before Opioid Rx

Doctors Urged to Check Patient Drug History Before ...

Opioid abuse down when physicians are legally obligated to check patient's drug history

is free, fast, and customized just for you!

Already a member?

Sign In Now »